Shenqi Medical's Qili® PRipper® Peripheral Cutting Balloon Receives NMPA Approval for Market Launch

Jun 14, 2025 07:30 CST Updated 07:30

Shenqi Medical

Cardiovascular Interventional Device Developer

Recently, Shanghai Shenqi Medical Technology Co., Ltd. (referred to as “Shenqi Medical^®"）independently developed by Shanghai Shenqi Medical Technology Co., Ltd."Qi Li^®PRipper^®Peripheral Cutting BalloonOfficially approved for marketing by the National Medical Products Administration (NMPA) (Registration Certificate No. 20253031104).

This product is intended for dilating lesions within the iliac artery, femoral artery, popliteal artery, and renal artery, and for treating obstructive lesions in autologous or artificial arteriovenous dialysis fistulas. The target lesion sites should have the following characteristics: minimal curvature in the proximal vessel segment and non-angled lesion segments (not exceeding 45°). The target lesion vessel diameter range is 5-8mm.

Copyright Statement: This platform aims to help medical and health professionals better understand the latest developments in relevant disease areas. The information content published on this platform does not imply agreement with its descriptions and viewpoints; it is solely for providing more information. If there are any copyright issues, we kindly request the rights holders to contact us, and we will address them as soon as possible. This information is intended exclusively for medical and health professionals to stay informed. Such information cannot replace professional medical guidance in any way and should not be considered as medical advice. If such information is used for purposes other than staying informed, this platform and its authors shall not bear any related responsibility.Contact email for cooperation:vascular@edoctor.work。